(Received for publication, June 2, 1995; and in revised form, July 26, 1995)
From the
Mutational damage to human mitochondrial DNA (mtDNA) can cause disorders in oxidative phosphorylation; speculation that such damage is involved in degenerative diseases and aging is common. We have detected deletions in mouse mtDNA which resemble those found in elderly humans or patients with certain mtDNA disorders. Five different mtDNA deletions, predicted from the positions of short, direct DNA repeats, were present in aged, but not young, mice. Deleted regions were surrounded by either exact or inexact repeats and occurred in both the major and minor regions of the mtDNA genome. The abundance of a particular deletion was generally related to the thermodynamic stability of the bounding repeat sequence. Deletions in aged mice were present at low levels (less than 0.01% of total mtDNA). However, in contrast to results from aged humans, deletions were more abundant in liver than in brain, heart, or skeletal muscle. These results make it possible to predict the location and relative abundance of deletions in any sequenced mtDNA, including inbred mouse strains differing in inherent natural lifespan. The inbred mouse model will allow a critical examination of the relationship between the presence and abundance of mtDNA deletions and the aging process.
Mammalian mitochondrial DNA (mtDNA) ()is a closed
circular DNA molecule of approximately l6 kb; several thousand mtDNA
molecules are present in the average somatic cell. Deletions in human
mtDNA have been associated with several mitochondrial disorders,
including Kearns-Sayre syndrome (KSS), progressive external
ophthalmoplegia, and Pearson's marrow-pancreas syndrome
(1-3; for review see (4) ). These mtDNA deletions vary in
size but usually delete genes encoding proteins essential for oxidative
phosphorylation as well as tRNAs and rRNAs needed for their synthesis.
Specific deletion events have been characterized in a number of
patients. The most common KSS deletion (4977 kb) is flanked by a
13-base pair direct repeat(5, 6) . Other deletions are
also flanked by exact or inexact direct repeats. Deletion junctions may
occur precisely at repeat boundaries or some distance
away(7, 8, 9) . The severity of symptoms in
KSS patients seems to depend in part on the ratio of normal to deleted
mtDNA molecules, with affected individuals often containing more than
50% deleted mtDNA molecules(10) .
Recent studies found the 4977-bp KSS mtDNA deletion at very low levels in normal human tissues; the levels seemed to increase with increasing age of the source(11, 12, 13, 14, 15) . Other mtDNA deletions have also been detected in elderly human patients(16, 17) . Estimates of the common KSS deletion in the elderly range from 0.007 to 0.1% (heart)(11, 13) , 0.001 to 12% (brain)(18, 19) , to 0.02 to 0.1% (muscle)(14, 20) . Differences between individuals and in measurement methods may account for some of the variability; in addition, significant regional variation was seen in brain. The low levels seen in aged individuals, compared to the much higher amounts in affected patients, make the role of mtDNA deletions in the aging process unclear. Using a PCR approach, we detected deletions in the mtDNA of aged mice; their location and abundance were predicted from the presence of direct DNA repeats in the mtDNA sequence. The observation of mtDNA deletions in mice makes possible a systematic examination of these deletions and their physiological significance.
Plasmid pTMM (Total MtDNA Mimic) was used as a
standard to measure total mtDNA in a DNA sample. A PCR-derived fragment
of mouse mtDNA(645-999) was ligated into pBS at
the SmaI site; the insert was cut at its unique BstXI
site and 301 bp of the human carbonic anhydrase III cDNA (697-812
plus 1140-1324) was inserted. The PCR product from mouse mtDNA
(using primers PL47 and PL48) is 355 bp; the product from pTMM is 656
bp. Plasmids pTMM and pDMM were purified by CsCl-ethidium bromide
centrifugation and concentrations determined by absorbance at 260 nm
and fluorometry. To show that the plasmids were internally consistent,
appropriate amounts were digested to release the common vector
backbone, electrophoresed, blotted, hybridized to a vector probe, and
the radioactive band analyzed on a Betascope 603 blot analyzer
(Betagen) to insure a 1:1 molar ratio. Standards were serially diluted
in 1.0 ng/µl
DNA and added to PCR reactions. The intensity on
ethidium bromide-stained agarose gels of the plasmid-derived PCR bands
were compared to mtDNA bands to determine absolute amounts.
Figure 1: Map of the mtDNA genome. The positions of direct repeats are indicated in relation to the D-loop region and the light strand origin of replication.
Mouse mtDNA repeat D-1 is the longest exact match and has a high estimated stability. Relevant features of the D-1 direct repeats, several other repeat pairs, and PCR primers are shown in Table 1and Table 2. PCR primers PL51/PL52 amplify a 4614-bp product from undeleted mtDNA under standard PCR conditions; mtDNA with a D-1 deletion yields a product of 748 bp. PCR amplification using a short PCR cycle to suppress synthesis of product from wild-type mtDNA revealed a possible D-1 deletion product in several tissues of a 19.5-month-old NMRI mouse (Fig. 2A). Southern blotting and DNA sequencing (not shown) confirmed that the 748 bp bands are products of mtDNA with one D-1 repeat and the intervening DNA deleted. Most tissues contained deleted mtDNA. We emphasize that this result is not quantitative; both the actual amount of DNA in 1 O.D. unit of a ``standard'' DNA preparation (21) can vary between samples, and different tissues have different mtDNA to nuclear DNA ratios. For example, heart (Fig. 2A), appears to have low levels of the D-1 deletion. Measurement by the quantitative assay described below showed this DNA sample to be low in both amplifiable mtDNA and nuclear DNA; the actual percentage of deleted mtDNA was similar to that of lung mtDNA.
Figure 2:
PCR detection of deletion D-1 in mtDNA of
aged mice. A, PCR amplification of mtDNA from tissues of one
aged mouse. B-D, PCR amplification of mtDNA from the liver (B), brain (C), and heart (D) of 13 aged
mice. Each reaction contained 1.0 µg of total DNA template, primers
PL51/PL52. Arrows indicate the 748-bp PCR product amplified
from deleted mtDNA. Ta = tail; Sk =
skin; Li = liver; Br = brain; He = heart; Sp = spleen; Lu =
lung; Ki = kidney; FQ = skeletal muscle
(forequarter); HQ = skeletal muscle (hindquarter); 1-13 =individual mice. Lanes marked 10 and 100 contain PCR reactions with 10 and 100 fg
of pDMM template as a positive control. Lane C is a control
PCR (no DNA template); lane M is an AluI digest of
pBR322 (910, 659, 656, 521, 403, and 281-226 bp). The high
molecular weight band in some reactions in panels B-D come
from one DNA stock used as a diluent (see ``Materials and
Methods'').
A similar search was made for D-1 deletions in several tissues of one young (6 week) C57 mouse (Fig. 3A) and in liver, heart, and brain DNA of 11 additional young C57 mice. In several independent PCR assays, no D-1 deletion products were seen in tissues of this one mouse nor in the other 11 heart or liver DNAs (data not shown). Faint 748 bp bands were visible in some young brain DNA samples (Fig. 3B); they hybridized to a mtDNA probe and were amplified by PCR primers internal to the original PL51/PL52 primer pair (data not shown). Occasionally, PCR amplification of other young mouse tissue DNAs showed very faint D-1 deletion bands. In these tissues, the amount of total mtDNA in young and old animals was comparable (data not shown). Estimates of deleted mtDNA amounts are discussed below.
Figure 3: PCR detection of deletion D-1 in mtDNA of young mice. A, PCR amplification of mtDNA from tissues of one young mouse. B, PCR amplification of mtDNA from brain of 12 young mice. Old = liver mtDNA from aged mouse no. 12; PCR conditions and other symbols are as in Fig. 1. The no DNA control for (B) was electrophoresed on a separate gel and is not shown.
Figure 4: Measurement of total and D-1 deletion mtDNA in liver DNA from an aged mouse. Lines indicate PCR products amplified from the control plasmids; arrows indicate products amplified from intact or deleted mtDNA. A, measurement of total mtDNA. PCR templates were: lane 1, 1.0 pg of pTMM; lane 2, 10 ng of liver DNA; lanes 3-7, 10 ng of liver DNA + 0.5, 1.0, 5.0, 10, and 20 pg of pTMM, respectively; lane 8, no DNA; lane 9, size marker (AluI digest of pBR322). B, measurement of D-1 deletion mtDNA. PCR templates were lane 1, 10 fg of pDMM; lane 2, 1 µg of liver DNA; lanes 3-7, 1 µg of liver DNA + 25, 50, 100, 200, and 500 fg of pDMM, respectively; lane 8, no DNA; lane 9, size marker.
The percentage of the D-1
(3867 bp) deletion in total mtDNA was determined for the tissue DNAs in Fig. 2A, the liver DNAs in Fig. 2B, and
for representative brain (Fig. 2C, animals 2, 5, and
12) and heart DNAs (Fig. 2D, animals 1, 2, and 12). For
the NMRI mouse shown in Fig. 2A, deleted mtDNA was most
abundant in the liver (3.3 10
%), kidney
(9.25
10
%) and lung (5
10
%), and less abundant in heart (3.3
10
%), skeletal muscle (2 samples, 1.33
10
% and 5
10
%) and brain
(5.8
10
%). Although the brain DNA sample had
an abundance of deleted molecules, the percentage was low because the
brain is rich in mtDNA; this was seen in all brain samples examined.
Deleted mtDNAs were too low to measure in tail, skin, and spleen. These
same relative levels were also seen in the other animals. Deleted mtDNA
was always most abundant in the liver, ranging from 3.3
10
% to 6
10
%. It was less
abundant in the heart (1.8
10
% to 3.3
10
%) and brain (3.5
10
% to 8
10
%).
The small amount of deleted mtDNA detected in brain DNA of some young animals was approximately 0.5-2.0 fg, near the detection limit of our PCR assay (the amount in old brain was typically 10-fold higher). The detection limit was determined by measuring the amount of deleted mtDNA in liver DNA of an old mouse and serially diluting this DNA 1:1 with liver DNA from a young mouse (where deletion products were not visible). The minimum detectable level of deleted mtDNA is 0.5-1.0 fg, against a ``background'' of 1 µg of total mouse DNA. We can detect lower levels of plasmid controls in reactions that lack a total DNA background. Primers may possibly bind to either nuclear DNA or undeleted mtDNA, effectively reducing the amount available to amplify deleted mtDNA (increasing primer concentration increases non-mtDNA artifact bands).
Figure 5: Detection of mtDNA deletions D-1, D-3, D-13, and D-17 in liver DNA of aged mice. Templates (1-13) were 1.0 µg of liver DNA from the 13 aged mice shown in Fig. 1. A, PCR with primers PL68 and PL69. The double arrow indicates products from mtDNA molecules with D-3 (upper band) and D-1 (lower band) deletions. B, PCR with primers PL69 and PL70. The arrow indicates products from mtDNA with D-13 deletions. C, PCR with primers PL85 and PL86. The arrow indicates products from mtDNA with a D-17 deletion. Lane C is a control PCR (no DNA template); lanes M are an AluI and a RsaI digest of pBR322, respectively; (RsaI: 2116, 1565, and 680 bp).
MtDNA deletions may also occur at inexact DNA repeats, i.e. direct repeats with one or more mismatches between them (D-13 to D-18 in Table 2). Primer pair PL69/PL70 amplifies a 445-bp product from mtDNA with a D-13 deletion. This product was visible in liver DNA from nine of 13 animals after 30 PCR cycles (Fig. 5B). A second inexact deletion, D-14, was not seen with a single PCR amplification using PL77/PL78 but was easily detectable after a second round of amplification with internal PCR primers (data not shown). Deletions arising from the D-16 repeat have never been detected. All of these deletions occur within base pairs 5,192-15,417 of mtDNA, the region first replicated by the newly initiated heavy strand as it proceeds toward the light strand origin (the ``major'' region). Direct repeat sequences also exist in the 5191 bp replicated subsequently (the ``minor'' region, from the light strand origin returning to the heavy strand origin). Two pairs of repeated sequences (D-17, D-18, Table 2) within the minor region were examined as potential inducers of deletions. An abundant deletion product was observed for D-17 (Fig. 5C) and confirmed by DNA sequencing. The second pair of direct repeats, D-18, does not seem to induce deletions (see below).
We also searched for D-3, D-13, and D-17 deletions in brain and heart DNA of six old mice and brain and liver DNA of six young mice. These deletions were present in both tissues of old mice, with D-1 and D17 again being the most visible. In contrast, only a few young mice had barely detectable levels of the D-17 deletion in liver and brain DNAs (data not shown).
Finally, to examine the generality of our predictions, we searched the rat mtDNA sequence (23) for direct repeats. A highly stable repeat is present (Table 2); PCR amplification revealed deleted mtDNA in liver of two aged rats (data not shown). Similar results were reported (30, 31) while this work was in progress.
Deletions in mtDNA are responsible for a number of human genetic disorders, primarily but not exclusively affecting muscle(1, 2, 3, 4) . Important questions regarding the involvement of mtDNA deletions in degenerative diseases and aging, i.e. the tissue and cellular distribution of deletions, the kinetics of their appearance, and the underlying mechanisms, are difficult to approach in human subjects. Although speculation is common in the literature that damage to mtDNA is an important factor in aging(32, 33, 34, 35, 36) , critical proof for a direct relationship is lacking. A decrease in mtDNA integrity could cause an overall decline in cell and tissue function with age. Alternatively, the increased level of mtDNA deletions and point mutations seen in elderly humans may simply reflect an accumulation of repair and replication errors occurring over time, with little relevance to the aging process.
Limited direct evidence exists to support a role for mtDNA damage in aging. While deleted mtDNA molecules are present in aged individuals, they are uncommon, with a single deletion generally constituting much less than 0.1% of total mtDNA. In contrast, human Kearns-Sayre patients have at least 20-80% deleted mtDNA molecules before symptoms of myopathy are seen(10) . However, the total damage to mtDNA during aging is difficult to estimate, as many mtDNA deletions and point mutations are possible and could accumulate with age(37) . Mouse models suitable for aging studies have been described(38, 39) ; inbred mouse strains differ in inherent life span and their life span can be further modified by environmental factors such as dietary restriction(40, 41) . We show here that it is possible to predict the presence and position of multiple deletions in the mtDNA of aged mice. Knowing the position of such frequently occurring mtDNA deletions will allow accurate measurements of their accumulation with time in these animals and make possible a critical test of their potential role in aging.
Six different deletions were observed in mtDNA of aged mice and rats (Table 2). The position and relative abundance of the individual deletions that we detected depend on the thermodynamic stability of direct repeats in the mtDNA sequences. Previous studies examining deletions in mouse mtDNA were not predictive(42, 43, 44, 45, 46) . Because we searched for deletions at predicted locations, PCR primers could be designed for efficient amplification and optimal product size. This approach tends to reduce or eliminate PCR artifactual bands, which is important for accurate quantitation. While this work was in progress, a similar strategy was used to detect the rat mtDNA deletion also observed here(30, 31) .
Although mtDNA
deletions were readily detected using PCR, the amount of deleted mtDNA
present in aged mice was small. Both the absolute level and the
percentage of the D-1 deletion in mtDNA of mouse tissues was quite low,
ranging from a high of 0.06% (liver) to 2
10
% (brain) to undetectable (less than 0.5 fg), in
individual animals. Levels of the other deletions were similar or
lower, as estimated from relative band intensity and dilution
experiments. Deletions were detectable in each of the 13 aged mice
examined, although not every mouse was positive in every tissue for
every deletion. In agreement with results in human, young mice
generally lacked detectable mtDNA deletions, although low levels of
some mtDNA deletion products were occasionally seen in brain samples.
This is unusual because brain does not accumulate deletions to high
levels in aged animals. In contrast, deletions were not detectable in
livers of young mice, a tissue that contains abundant deletions in aged
mice. The ratio of mitochondrial DNA to nuclear DNA in these two
tissues is roughly equivalent. (
)
There are clear differences between the results reported here for aged mice and previous reports from human subjects; such differences suggest that a generalized aging process involving mtDNA deletions may not exist. In mice, the deletions were most abundant in liver, moderately abundant in kidney and lung, and either low or absent in brain, heart, muscle, tail, skin, and blood. This distribution differs from aged humans where deletions are reportedly most abundant in brain, muscle, and heart, and less abundant in liver(14, 34) . Different mtDNA measurement methods and individual diversity among the small number of elderly humans examined may account for some, but not all, of the discrepancy. This distribution difference, as well as the differential accumulation with age noted above for brain and liver, while not completely inconsistent with an involvement of mtDNA deletions in aging, does indicate that differences in induction and accumulation do exist between tissues and between species. It has been hypothesized, based on the human data, that mtDNA deletions are most abundant in tissues with high metabolic and low mitotic activity(19, 47) , a suggestion that now appears inaccurate. Most tissues in the adult have low mitotic activity; for example, neither neurons nor hepatocytes divide. More importantly, brain and liver have large and equal oxygen consumption rates, the highest among vertebrate tissues(48) . The two tissues do differ markedly in their relative sensitivity to anoxia, but the difference results from the presence of stored substrates for ATP production in liver, not a lower metabolic rate in liver than in brain mitochondria. Thus, on the basis of overall mitochondrial function as measured by oxygen consumption, brain and liver are both metabolically active and mitotically quiet, and would be expected to have high deletion levels, yet they differ dramatically. The observed differences in mtDNA deletion levels seen between tissues in mice and humans suggests that environmental and metabolic differences between these species may affect deletion levels more than the aging process.
The detailed mechanism(s) producing the deletions and the features of the direct repeats which determine the frequency of a particular mtDNA deletion are not well understood, but the thermodynamic stability of the repeat pairs examined here seems critical to their ability to cause deletions. The most stable repeats that we examined (Table 2) were associated with the most abundant deletions. Deletions were detected in both the major and minor regions of the mtDNA genome. D-17, an abundant deletion, is located in the minor region. Apparently, as long as replication origins are intact, repeat stability is more important than genome position. The D-13 and D-14 repeat pairs are less stable and deletions between them are much less abundant. Three pairs of direct repeats (D-2, D-16, and D-18) never produced a detectable level of deletions. D-16 and D-18 are inexact repeats whose estimated relative stability is the lowest of those calculated. D-2 is the shortest repeat we examined (13 nucleotides) and is estimated to be only slightly more stable than the D-13 and D-14 repeats (Table 2), which produce very low levels of deletions. Given the uncertainties in nearest-neighbor calculations, the agreement appears excellent. It is clearly possible that other factors, such as distance separating repeat pairs or potential secondary structure in mtDNA, might affect the efficiency of the deletion mechanism(s) and modulate the effects of repeat stability.
We emphasize that deletions may arise by more than one mechanism, some not involving direct repeats. Some studies of deletions associated with mitochondrial disorders in humans have reported associated repeats as short as four nucleotides. The repeats were often not located precisely at deletion junctions and the deletion encompassed neither, one, or both repeat copies(7, 8, 9, 16, 49) . This type of deletion and associated repeat does not fit the pattern seen above. Indeed, most of these repeats are so short and inexactly spaced that their association with the deletion is likely due to chance.
Several deletion mechanisms have been
proposed(3, 6, 7, 8) , based on the
presence of direct repeats at deletion junctions and their sequence
characteristics. Sequencing of deletions involving mismatched repeats
(D-13, D-14, and D-17) has revealed that deletion events often occur
within the repeat rather than precisely at an end, producing a
remaining ``hybrid'' repeat. This result, and the
implications of it and secondary structure on the mechanisms
responsible for mtDNA deletions, will be discussed separately.
Finally, the deleted mtDNA molecules present in patients with mitochondrial disorders are believed to arise from a single deleted molecule present very early in development. This deleted molecule is amplified and partitioned during oogenesis and development to comprise the majority population in the affected tissue. DNA sequences of deletion junctions support this hypothesis; patients usually harbor a single deletion. In contrast, our results suggest that the deletions that accumulate in aging mice resulted from independent deletion events because multiple deletions were present in the same tissue. The ability to predict the location of mtDNA deletions in inbred mice now makes it possible to ask whether individual cells within a tissue harbor more than one deletion, how deleted mtDNAs are distributed within the cells of a single tissue, and how the kinetics and abundance of mtDNA deletions are related to aging. Answers to these questions will help us understand the physiological consequences of these deletions and determine if the pattern and rate of accumulation is consistent with a role in aging.